Conversely, a strong negative correlation was found between IFN-γ, GM-CSF and TNF-α levels in RR-SMS patients, as well as between GM-CSF, TNF-α and CMV-IgG antibody titers in PP-MS patients (Figures 5B, B.1). This evidence concerns the gene CSF2 and myeloid sarcoma.